354 related articles for article (PubMed ID: 8382999)
1. Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients.
Beljaards RC; Kaudewitz P; Berti E; Gianotti R; Neumann C; Rosso R; Paulli M; Meijer CJ; Willemze R
Cancer; 1993 Mar; 71(6):2097-104. PubMed ID: 8382999
[TBL] [Abstract][Full Text] [Related]
2. Lymphomatoid papulosis and Ki-1 (CD30)-positive cutaneous large cell lymphomas.
Kaudewitz P; Burg G
Semin Diagn Pathol; 1991 May; 8(2):117-24. PubMed ID: 1651550
[No Abstract] [Full Text] [Related]
3. Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large-cell lymphomas of T-cell origin. A clinicopathologic and immunohistochemical study in 20 patients.
Beljaards RC; Meijer CJ; Scheffer E; Toonstra J; van Vloten WA; van der Putte SC; Geerts ML; Willemze R
Am J Pathol; 1989 Dec; 135(6):1169-78. PubMed ID: 2556926
[TBL] [Abstract][Full Text] [Related]
4. CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group.
Paulli M; Berti E; Rosso R; Boveri E; Kindl S; Klersy C; Lazzarino M; Borroni G; Menestrina F; Santucci M
J Clin Oncol; 1995 Jun; 13(6):1343-54. PubMed ID: 7751878
[TBL] [Abstract][Full Text] [Related]
5. Classification of primary cutaneous large cell lymphomas.
Willemze R; Beljaards RC; Rijlaarsdam U
Dermatol Clin; 1994 Apr; 12(2):361-73. PubMed ID: 8045048
[TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous lymphomas: a study of 37 cases.
Andrès P; Lepagney ML; Bureau B; Litoux P; Dréno B
Int J Dermatol; 1997 Aug; 36(8):582-6. PubMed ID: 9329888
[TBL] [Abstract][Full Text] [Related]
7. A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma.
Kinney MC; Collins RD; Greer JP; Whitlock JA; Sioutos N; Kadin ME
Am J Surg Pathol; 1993 Sep; 17(9):859-68. PubMed ID: 8394652
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous pleomorphic T-cell lymphoma expressing CD30 antigen.
Gianotti R; Alessi E; Cavicchini S; Berti E
Am J Dermatopathol; 1991 Oct; 13(5):503-8. PubMed ID: 1659246
[TBL] [Abstract][Full Text] [Related]
9. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment.
Bekkenk MW; Geelen FA; van Voorst Vader PC; Heule F; Geerts ML; van Vloten WA; Meijer CJ; Willemze R
Blood; 2000 Jun; 95(12):3653-61. PubMed ID: 10845893
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment.
Willemze R; Beljaards RC
J Am Acad Dermatol; 1993 Jun; 28(6):973-80. PubMed ID: 8388410
[TBL] [Abstract][Full Text] [Related]
11. Primary cutaneous CD30-positive anaplastic large cell lymphoma. Report of 27 cases.
Krishnan J; Tomaszewski MM; Kao GF
J Cutan Pathol; 1993 Jun; 20(3):193-202. PubMed ID: 7690050
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous Ki-1(CD30) positive anaplastic large cell lymphoma in childhood.
Tomaszewski MM; Moad JC; Lupton GP
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):857-61. PubMed ID: 10321635
[TBL] [Abstract][Full Text] [Related]
13. Primary "cutaneous" T-cell anaplastic large cell lymphoma, CD30+, neutrophil-rich variant with subcutaneous panniculitic lesions, in a post-renal transplant patient: report of unusual case and literature review.
Salama S
Am J Dermatopathol; 2005 Jun; 27(3):217-23. PubMed ID: 15900125
[TBL] [Abstract][Full Text] [Related]
14. CD30-positive cutaneous large cell lymphomas. A comparative study of clinicopathologic and molecular features of 16 cases.
Macgrogan G; Vergier B; Dubus P; Beylot-Barry M; Belleannee G; Delaunay MM; Eghbali H; Beylot C; Rivel J; Trojani M; Vital C; De Mascarel A; Bloch B; Merlio JP
Am J Clin Pathol; 1996 Apr; 105(4):440-50. PubMed ID: 8604686
[TBL] [Abstract][Full Text] [Related]
15. Statistical evaluation of diagnostic and prognostic features of CD30+ cutaneous lymphoproliferative disorders: a clinicopathologic study of 65 cases.
Vergier B; Beylot-Barry M; Pulford K; Michel P; Bosq J; de Muret A; Beylot C; Delaunay MM; Avril MF; Dalac S; Bodemer C; Joly P; Groppi A; de Mascarel A; Bagot M; Mason DY; Wechsler J; Merlio JP
Am J Surg Pathol; 1998 Oct; 22(10):1192-202. PubMed ID: 9777981
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients.
Massone C; Chott A; Metze D; Kerl K; Citarella L; Vale E; Kerl H; Cerroni L
Am J Surg Pathol; 2004 Jun; 28(6):719-35. PubMed ID: 15166664
[TBL] [Abstract][Full Text] [Related]
17. CD30-positive cutaneous T-cell lymphoma with concurrent solid tumour.
Au WY; Yeung CK; Chan HH; Wong RW; Shek TW
Br J Dermatol; 2002 Jun; 146(6):1091-5. PubMed ID: 12072086
[TBL] [Abstract][Full Text] [Related]
18. [CD30 positive large T-cell primary cutaneous lymphoma].
Marschalkó M; Szigeti A; Hársing J; Kelényi G; Horváth A
Orv Hetil; 1998 May; 139(21):1305-8. PubMed ID: 9632925
[TBL] [Abstract][Full Text] [Related]
19. CD30-CD30 ligand interaction in primary cutaneous CD30(+) T-cell lymphomas: A clue to the pathophysiology of clinical regression.
Mori M; Manuelli C; Pimpinelli N; Mavilia C; Maggi E; Santucci M; Bianchi B; Cappugi P; Giannotti B; Kadin ME
Blood; 1999 Nov; 94(9):3077-83. PubMed ID: 10556192
[TBL] [Abstract][Full Text] [Related]
20. Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders.
Sciallis AP; Law ME; Inwards DJ; McClure RF; Macon WR; Kurtin PJ; Dogan A; Feldman AL
Mod Pathol; 2012 Jul; 25(7):983-92. PubMed ID: 22388754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
